Fundraising FoxMolecularmd
Portland, US · Delaware corporation
Find your way into Molecularmd
Sign up to see every warm intro you have to Molecularmd
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Molecularmd team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RD
Ryan DunlapExecutive
TS
Teri SwiftExecutive
SD
Sheridan D. SnyderNamed on SEC filing
Board
CG
Chad GalderisiBoard director
SG
Sheridan G. SnyderBoard director
RB
Richard BrandewieBoard director
Reported raises · per SEC filings
Form D private placements$10.6M disclosed across 3 rounds · 2012–2017
▶$2.1MraisedFeb 2017 · 7 investors · BiotechnologyRule 506(b)
▶$2.1MraisedFeb 2017 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chad GalderisiExecutive Officer
- Sheridan D. SnyderExecutive Officer, Director
- Sheridan G. SnyderDirector
- Matthew RiceDirector
- Frederick EibelExecutive Officer
- Ryan DunlapExecutive Officer
- Peter MaagDirector
- Cindy SpittleExecutive Officer
- Drew GrahamDirector
- Offering amount
- $2.1M
- Amount sold
- $2.1M
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedJul 2016 · 6 investors · BiotechnologyRule 506(b)
▶$500KraisedJul 2016 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sheridan D. SnyderExecutive Officer, Director
- Ryan DunlapExecutive Officer
- Offering amount
- $2M
- Amount sold
- $500K
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8MraisedFeb 2012 · 4 investors · BiotechnologyRule 506(b)
▶$8MraisedFeb 2012 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard BrandewieDirector
- Chad GalderisiDirector
- Teri SwiftExecutive Officer
- Sheridan D. SnyderExecutive Officer, Director
- Stephane WongExecutive Officer
- Sheridan G. SnyderExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $8M
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Molecularmd raised?
- Molecularmd has disclosed $10.6M raised across 3 rounds.
- Where is Molecularmd headquartered?
- Molecularmd is headquartered in Portland, US.